CM-Path Chairperson, Professor David Harrison

David Harrison MD, DSc, FRCPath, FRCPEd, FRCSEd graduated from the University of Edinburgh and trained as a histopathologist. Whilst clinically specialising in liver and kidney, his research interests are broader, coming under the general banner of systems biology and AI applied to pathology. He is currently Professor of Pathology in St Andrews, and Director of Development for Laboratory Medicine in NHS Lothian. David holds honorary chairs in Glasgow, Florida, Edinburgh, the last of these where he was Professor of Pathology for 12 years and Director of the Edinburgh Cancer Research Centre.  Alongside his clinical and academic work, David is director in several small biotech companies, he chairs the UK Committee on Carcinogenicity and is Chairperson of a number of Charities. He is Director of iCAIRD (Industrial Centre for AI Research in Digital Diagnostics), a Scotland-wide consortium funded by Innovate UK.

CM-Path Executive Group

Work of the CM-Path initiative is overseen by an Executive Group, in order to maintain a strategic view and ensure delivery of its objectives. The Executive Group will ensure information-sharing and promote collaboration between Workstreams. It will seek opportunities to promote cellular molecular pathology, where appropriate, as a key component of oncology research.


Professor Louise Jones, Workstream 1 Lead

Abeer Shaaban

Dr Abeer Shaaban, Workstream 2 Lead


Professor Gareth Thomas, Workstream 3 Lead

Clare Verrill New

Professor Clare Verrill, Workstream 4 Lead


Dr Bridget Wilkins, Royal College of Pathologists Representative


Professor Mark Arends, Pathological Society Representative

Dr Ian Lewis, NCRI Representative

RS sitting cropped

Dr Rowena Sharpe, CRUK, Funder Representative


Dr Raffaella Tate, Consumer Representative

Dr Matthew Hobbs, Prostate Cancer UK, Funder Representative